Actiblok IPR 25 Tablet
Marketer
Biocon
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Actiblok IPR 25 Tablet
Cardiogard 25mg tablets, a beta-blocker medication, effectively manages hypertension, angina pectoris, and cardiac arrhythmias. This medication also contributes to migraine prevention and reduces the risk of future strokes and myocardial infarctions. Dosage and frequency are individualized based on the specific condition and its severity; it may be prescribed alone or in conjunction with other therapies. Administer consistently at the same time daily, with or without food, for optimal results. Complete therapeutic benefit may take several weeks, and continued use, even with symptom improvement, is often necessary for life. Discontinuation can lead to condition exacerbation. Common, typically mild and transient, adverse effects include fatigue, cephalgia, depressive symptoms, diarrhea, skin rash, bradycardia, lightheadedness, and nausea. Less frequent side effects can include dyspnea and hypotension. To minimize adverse events, a gradual dose escalation is recommended. Report persistent or bothersome side effects to your physician. Prior to initiation, disclose any hepatic impairment. Cardiogard 25mg is contraindicated in patients with bradycardia, severe circulatory compromise, advanced heart failure, or hypotension. Pregnant or lactating individuals require medical consultation before use. Individual suitability should be determined by a physician, and regular blood pressure monitoring is essential to assess treatment efficacy. Alcohol consumption should be avoided due to potential side effect augmentation.
Primary Ingredients of Actiblok IPR 25 Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Actiblok IPR 25 Tablet
Managing angina pectoris (chest pain stemming from heart issues) | Addressing cardiac arrhythmias | Reducing the risk of myocardial infarction | Hypertension (high blood pressure) management | Migraine prophylaxis
Major Benefits of Actiblok IPR 25 Tablet:
Follow your doctor's instructions or the product label for proper administration. Actiblok IPR 25 Tablets can be taken with or without food; however, consistent timing is recommended. To optimize absorption, it's advisable to avoid consuming Actiblok IPR 25 Tablets with meals high in fat, including those containing olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, or meat.
Common Side effects of Actiblok IPR 25 Tablet:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Actiblok IPR 25 Tablet:
Follow your doctor's instructions or the product label for proper administration. Actiblok IPR 25 Tablets can be ingested with or without food; however, consistent timing is recommended. Limit consumption of Actiblok IPR 25 Tablets with meals high in fat, including those containing olive oil, nuts (like Brazil nuts), dark chocolate, butter, and meats.
How Actiblok IPR 25 Tablet works:
CardioGuard 25mg tablets, a sustained-release beta-adrenergic blocker, target cardiac function. This medication reduces heart rate and improves the heart's pumping efficiency, enhancing circulatory flow.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while taking Actiblok IPR 25 Tablet is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Actiblok IPR 25 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and Actiblok IPR 25 Tablet use appear compatible. Available human data indicate minimal infant risk associated with the medication.
DrivingUNSAFE
Taking Actiblok IPR 25 Tablet may cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects arise.
KidneySAFE IF PRESCRIBED
Actiblok IPR 25 Tablets pose no safety concerns for patients with kidney impairment; no dosage modification is necessary.
LiverCAUTION
Patients with liver impairment should use Actiblok IPR 25 Tablet cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Actiblok IPR 25 Tablet :
Should you forget to take your Actiblok IPR 25 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Actiblok IPR 25 Tablet
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |



